A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer
Abstract About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological and clinical factors are used to select patients f...
Guardado en:
Autores principales: | Havjin Jacob, Luka Stanisavljevic, Kristian Eeg Storli, Kjersti E. Hestetun, Olav Dahl, Mette P. Myklebust |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9dd3caffa57b43dc8719f849893eb89b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
por: Lian Zheng, et al.
Publicado: (2021) -
Ferroptosis-Associated Classifier and Indicator for Prognostic Prediction in Cutaneous Melanoma
por: Hao Zeng, et al.
Publicado: (2021) -
A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes
por: Naofumi Asano, et al.
Publicado: (2019) -
RFMirTarget: predicting human microRNA target genes with a random forest classifier.
por: Mariana R Mendoza, et al.
Publicado: (2013) -
Prognostic role of oxytocin receptor in colon adenocarcinoma
por: Sun Junjie, et al.
Publicado: (2021)